Stock OCUL OCULAR THERAPEUTIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Ocular Therapeutix, Inc.

Equities

OCUL

US67576A1007

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
6 USD -1.64% Intraday chart for Ocular Therapeutix, Inc. -4.61% +34.53%
05-16 Transcript : Ocular Therapeutix, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
05-07 Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $14.8M, vs. Street Est of $15.4M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
OCULAR THERAPEUTIX, INC. Stock Ocular Therapeutix, Inc.
 945M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
 331B
ABBVIE INC. Stock AbbVie Inc.
 288B
  1. Stock Market
  2. Equities
  3. OCUL Stock
  4. Charts Ocular Therapeutix, Inc.
  5. Sector Chart